Ju Fu Tang Biotech Holdings Co., Ltd. filed its Monthly Return for Equity Issuer with Hong Kong Exchanges and Clearing on 6 October 2026, disclosing that both its authorised and issued share capital remained unchanged during September 2026.

• Authorised share capital closed the month at 500.00 million ordinary shares with a par value of HKD 0.16, equal to HKD 80.00 million.

• Issued share capital was steady at 301.86 million ordinary shares, and the company continued to hold zero treasury shares. As no new shares were issued or repurchased, total issued and treasury share counts were unchanged from August.

• Ju Fu Tang Biotech confirmed compliance with the Hong Kong Exchange’s minimum 25 percent public-float requirement as of 30 September 2026.

• Under its 24 March 2016 Share Option Scheme, 9.14 million options (exercise price: HKD 0.163; grant date: 18 March 2022; expiry: 17 March 2027) remained outstanding. No options were exercised and no shares were issued or transferred during the month.

The issuer attested that all regulatory obligations, including receipt of consideration for any securities issued and adherence to Hong Kong Listing Rules, have been fulfilled.